Screening, risk assessment, and the approach to therapy in patients with prostate cancer
β Scribed by Stephen J. Freedland
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 310 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Prostate cancer risk assessment has become increasingly complex, with a long and growing menu of risk assessment tools available. Instrument selection for clinical practice and research must balance accuracy, validation, and applicability.
## Abstract ## BACKGROUND. The presence of multiple determinants of aggressive cancer biology may impact prostate cancerβspecific mortality (PCSM) rates compared with fewer factors. The authors estimated PCSM after radiation therapy with shortβcourse androgen suppression therapy (RT+AST) or radica
## Abstract In this review the preoperative risk assessment and prevention of complications in patients undergoing esophagectomy for cancer is discussed. Age, pulmonary and cardiovascular condition, nutritional status, and neoadjuvant chemo(radio)therapy are known predictive factors. None of these